OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes
Farhang Modaresi, Kaivan Talachian
Pharmaceutical Medicine (2022) Vol. 36, Iss. 6, pp. 387-400
Closed Access | Times Cited: 13

Showing 13 citing articles:

Nutrition, endocannabinoids, and the use of cannabis: An overview for the nutrition clinician
Lindsey Russell, Kayla Condo, Tiffany DeFlorville
Nutrition in Clinical Practice (2024) Vol. 39, Iss. 4, pp. 815-823
Open Access | Times Cited: 5

Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts
Gérard Mick, Pascal Douek
Pain and Therapy (2024) Vol. 13, Iss. 5, pp. 1063-1094
Open Access | Times Cited: 4

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment
Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access

Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery Vehicles
Zahra Khabir, Connie Partalis, Jimit Vijay Panchal, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 798-798
Open Access | Times Cited: 7

Cannabinoid-Based Ocular Therapies and Formulations
Sofia M. Saraiva, Lucía Martín‐Banderas, Matilde Durán‐Lobato
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1077-1077
Open Access | Times Cited: 7

Cannabidiol's impact on drug-metabolization
Claudia Stöllberger, Josef Finsterer
European Journal of Internal Medicine (2023) Vol. 118, pp. 6-13
Closed Access | Times Cited: 5

Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors
Morgan Scott-Dennis, Fikri A. Rafani, Yicheng Yi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5

Effects of combined cannabidiol (CBD) and hops (Humulus lupulus) terpene extract treatment on RAW 264.7 macrophage viability and inflammatory markers
Inga Dammann, Claudia Keil, I. Hardewig, et al.
Natural Products and Bioprospecting (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3

The State of Synthetic Cannabinoid Medications for the Treatment of Pain
Anca Maglaviceanu, Miki Peer, Jason S. Rockel, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 597-612
Closed Access

The proof is in the pudding: Patient Engagement in Studying Cannabidiol in Mild Cognitive Impairment
Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, et al.
(2024)
Closed Access

Δ9-Tetrahydrocannabinol Effects on Respiration and Heart Rate Across Route of Administration in Female and Male Mice
Lucas Laudermilk, Julie A. Marusich, Jenny L. Wiley
Cardiovascular Toxicology (2023) Vol. 23, Iss. 11-12, pp. 349-363
Closed Access | Times Cited: 1

Verification of the analgesic properties of natural compounds of cannabinoid origin in Danio rerio model of nociception
Wojciech Ozimkiewicz, Ewelina Iskra, Renata Żelazowska, et al.
Scientiae Radices (2023) Vol. 2, Iss. 3, pp. 229-246
Open Access | Times Cited: 1

Intérêt et mécanismes d’action de la kétamine dans le traitement de l’addiction à l’alcool – Revue des études cliniques et précliniques
Fahd François Hilal, Jérôme Jeanblanc, Mickaël Naassïla
Biologie Aujourd hui (2023) Vol. 217, Iss. 3-4, pp. 161-182
Closed Access | Times Cited: 1

Page 1

Scroll to top